Coverage
-
May 21, 2018
A California federal judge on Monday said she's unlikely to grant drugmaker Collidion Inc.'s bid to trim rival Sonoma Pharmaceuticals Inc.'s trade secrets suit, saying the claims probably aren't time-barred and that it's too soon to say whether Sonoma was injured by the alleged theft.
2 other articles on this case.
View all »